Urgent.News

What's breaking now, across thousands of outlets.

AI

Microsoft's Maia 300 swaps raw compute for a 2.5x memory bandwidth gain as it moves to make in-house silicon its main AI engine while claiming a 40% efficiency bump — could going the Google route be the pin that pops the Nvidia AI bubble?

Can in-house chips pop the AI bubble? Microsoft's Maia 300 makes the case, but Nvidia shrugged off the news with a 1.29% decline.

Microsoft's Maia 300 swaps raw compute for a 2.5x memory bandwidth gain as it moves to make in-house silicon its main AI engine while claiming a 40% efficiency bump — could going the Google route be the pin that pops the Nvidia AI bubble?

Microsoft's upcoming Maia 300 accelerators will replace Nvidia GPUs as the primary inference engine for the company's products and services, making the move in-house similar to Google and Amazon. The Maia 300 trades a modest 36% compute gain for a 2.5x memory bandwidth increase compared to the Maia 200, betting on memory-bound decode as the key to efficiency.

With production set for 2027, the accelerators will be scaled to multi-gigawatt deployments and will be manufactured on TSMC's N2P process, with memory-controller and I/O functions split onto separate dies. The new architecture aims to reduce data transfer bottlenecks by keeping data closer to the compute that utilizes it, through a non-uniform memory layout, software-managed on-die SRAM, and narrower number formats.

While the move is seen as a significant step towards in-house silicon, it remains to be seen if the shift will be the final catalyst to break Nvidia's AI bubble, as the largest buyers of AI hardware continue to rely on Nvidia's margins.

Written by urgent.news from TechRadar's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at techradar.com →

More in AI

1+1 is always 2: Bringing determinism back to AI-Assisted engineering

Maxim Magaziner explores how AI-assisted engineering, stronger testing, automation, and technical leadership can help teams build software faster without sacrificing quality.

  • AI agents generate functional applications from simple prompts
  • Determinism achieved through path-scoped rules in large codebases
  • LangGraph ensures consistent multi-step AI workflows

AI Drug Discovery in 2026: How Artificial Intelligence Is Changing Medicine

Originally published on The Daily Flare . KEY TAKEAWAYS AlphaFold's 2024 Nobel Prize validated AI's central role in biology, with over 200 million protein structures freely available to researchers.

  • AI drug discovery awarded Nobel Prize in Chemistry in 2024
  • AI-designed drugs enter human trials by 2026
  • AlphaFold predicts protein structures and interactions

More from Saturday 17 October →